Arrowhead Pharmaceuticals (ARWR) Shares Outstanding (Entity) (2010 - 2026)
Arrowhead Pharmaceuticals (ARWR) posted Shares Outstanding (Entity) of 141.14 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 2.2% from 138.14 million a year earlier and up 0.4% from the prior quarter.
Powered by 
Analysis
Arrowhead Pharmaceuticals (ARWR) Shares Outstanding (Entity) (2010 - 2026) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Arrowhead Pharmaceuticals' Shares Outstanding (Entity) came in at 135.7 million, up 9.1% from FY2024.
- Annual Shares Outstanding (Entity) has increased for 15 consecutive fiscal years, with a five-year compound annual growth rate of 5.8% (FY2020 to FY2025).
- In prior fiscal years, Arrowhead Pharmaceuticals' Shares Outstanding (Entity) was 124.38 million in FY2024 (+15.9%), 107.31 million in FY2023 (+1.3%), 105.96 million in FY2022 (+1.6%) and 104.33 million in FY2021 (+1.9%).
- The fiscal Q3 2026 figure stands as the highest quarterly Shares Outstanding (Entity) in data going back to fiscal Q3 2010.
- On a year-over-year basis, Shares Outstanding (Entity) has increased in each of the last 61 quarters, with growth averaging 9.7% over the last eight quarters.
- Over the past five years, the year-over-year growth in Shares Outstanding (Entity) ranged from 1.1% (fiscal Q2 2023) to 16.8% (fiscal Q1 2025).
- According to Business Quant data, Shares Outstanding (Entity) for the three prior fiscal quarters was 140.57 million (Q2 2026), 137.39 million (Q1 2026) and 135.7 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.60 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.35 Mn |
| 10 | Arrowhead Pharmaceuticals | 9.24 Bn | 4.02 Bn | - | 141.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 141.14 Mn |
| Mar 31, 2026 | 140.57 Mn |
| Dec 31, 2025 | 137.39 Mn |
| Sep 30, 2025 | 135.70 Mn |
| Jun 30, 2025 | 138.14 Mn |
| Mar 31, 2025 | 138.06 Mn |
| Dec 31, 2024 | 125.57 Mn |
| Sep 30, 2024 | 124.38 Mn |
| Jun 30, 2024 | 124.23 Mn |
| Mar 31, 2024 | 124.13 Mn |
| Dec 31, 2023 | 107.50 Mn |
| Sep 30, 2023 | 107.31 Mn |
| Jun 30, 2023 | 107.10 Mn |
| Mar 31, 2023 | 106.87 Mn |
| Dec 31, 2022 | 106.14 Mn |
| Sep 30, 2022 | 105.96 Mn |
| Jun 30, 2022 | 105.80 Mn |
| Mar 31, 2022 | 105.70 Mn |
| Dec 31, 2021 | 104.80 Mn |
| Sep 30, 2021 | 104.33 Mn |
API Access
Arrowhead Pharmaceuticals Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=ARWR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "ARWR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=ARWR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();